C. Cebotaru

1.0k total citations
24 papers, 517 citations indexed

About

C. Cebotaru is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, C. Cebotaru has authored 24 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in C. Cebotaru's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). C. Cebotaru is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). C. Cebotaru collaborates with scholars based in Romania, United States and United Kingdom. C. Cebotaru's co-authors include Tudor–Eliade Ciuleanu, Valentina Tzekova, John D. Hainsworth, G. Pover, Clive Morris, Phillip J. Stella, Pierre Fenaux, Vincent Ribrag, Joachim von Pawel and D. Ross Camidge and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Cancer.

In The Last Decade

C. Cebotaru

23 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Cebotaru Romania 12 275 177 150 122 89 24 517
Zebing Liu China 13 249 0.9× 190 1.1× 113 0.8× 134 1.1× 125 1.4× 38 514
Sandeep Reddy United States 8 159 0.6× 222 1.3× 150 1.0× 93 0.8× 138 1.6× 18 458
Shih-Chen Yu Taiwan 14 217 0.8× 142 0.8× 48 0.3× 256 2.1× 117 1.3× 17 589
Laura López-Vicente Spain 4 265 1.0× 166 0.9× 54 0.4× 66 0.5× 88 1.0× 4 480
Ulla Aspenblad Sweden 11 199 0.7× 181 1.0× 74 0.5× 114 0.9× 120 1.3× 13 510
Alexandr O. Ivantsov Russia 16 257 0.9× 360 2.0× 172 1.1× 263 2.2× 248 2.8× 51 715
Véronique Cabaret France 9 158 0.6× 392 2.2× 40 0.3× 90 0.7× 72 0.8× 20 588
Annie Jean United States 9 345 1.3× 329 1.9× 51 0.3× 174 1.4× 286 3.2× 10 758
Karin Tyburski United States 6 230 0.8× 291 1.6× 99 0.7× 97 0.8× 33 0.4× 9 510

Countries citing papers authored by C. Cebotaru

Since Specialization
Citations

This map shows the geographic impact of C. Cebotaru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Cebotaru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Cebotaru more than expected).

Fields of papers citing papers by C. Cebotaru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Cebotaru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Cebotaru. The network helps show where C. Cebotaru may publish in the future.

Co-authorship network of co-authors of C. Cebotaru

This figure shows the co-authorship network connecting the top 25 collaborators of C. Cebotaru. A scholar is included among the top collaborators of C. Cebotaru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Cebotaru. C. Cebotaru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fekete, Zsolt, et al.. (2024). Challenges in the Management of Stage IV Clear Cell Sarcoma of Soft Tissue in Young Adults: Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 17(1). 988–994.
2.
3.
Vergote, Ignace, Matthew A. Powell, Michael Teneriello, et al.. (2020). Second-line lenvatinib in patients with recurrent endometrial cancer. Gynecologic Oncology. 156(3). 575–582. 54 indexed citations
4.
5.
Georgiu, Carmen, et al.. (2016). Intracranial immature teratoma with a primitive neuroectodermal malignant transformation - case report and review of the literature.. PubMed. 57(4). 1389–1395. 16 indexed citations
6.
Bondarenko, Igor, Antonella Ingrosso, Paul Bycott, Sinil Kim, & C. Cebotaru. (2015). Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer. BMC Cancer. 15(1). 339–339. 14 indexed citations
7.
Cebotaru, C., et al.. (2015). Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review. Medicine and Pharmacy Reports. 89(2). 203–211. 5 indexed citations
8.
Crişan, Nicolae, et al.. (2015). Retroperitoneal perirenal myxoid liposarcoma. Journal of Surgical Case Reports. 2015(3). rju127–rju127. 2 indexed citations
9.
10.
Coyle, Vicky M., Dan Lungulescu, Alexander B. Niculescu, et al.. (2013). A randomised double-blind placebo-controlled phase II study of AGI004 for control of chemotherapy-induced diarrhoea. British Journal of Cancer. 108(5). 1027–1033. 1 indexed citations
11.
Cebotaru, C., et al.. (2012). P1.16 Detection of Circulating Tumor Cells Could Adjust Therapy in Poor Risk Germ Cell Tumors? A Pilot Study. Annals of Oncology. 23. v17–v17. 1 indexed citations
12.
Ciuleanu, Tudor–Eliade, et al.. (2012). First-line chemotherapy with topotecan and etoposide in advanced small cell lung cancer. A phase II study.. PubMed. 7(1). 43–6. 1 indexed citations
13.
Pawel, Joachim von, David R. Spigel, Mircea Dediu, et al.. (2010). 進行性NSCLC患者におけるカルボプラチンとパクリタキセルを併用した,TRAIL-R1アゴニスト単クローン抗体マパツムマブの無作為化第2相試験. Journal of Clinical Oncology. 28. 953. 1 indexed citations
14.
Hainsworth, John D., C. Cebotaru, Tudor–Eliade Ciuleanu, et al.. (2010). A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens. Journal of Thoracic Oncology. 5(10). 1630–1636. 134 indexed citations
15.
Pawel, Joachim von, David R. Spigel, Mircea Dediu, et al.. (2010). A randomized phase II trial of mapatumumab, a TRAIL-R1 agonist monoclonal antibody, in combination with carboplatin and paclitaxel in patients with advanced NSCLC.. Journal of Clinical Oncology. 28(18_suppl). LBA7501–LBA7501. 22 indexed citations
16.
Tzekova, Valentina, C. Cebotaru, Tudor–Eliade Ciuleanu, et al.. (2008). Efficacy and safety of AZD6244 (ARRY-142886) as second/third-line treatment of patients (pts) with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 26(15_suppl). 8029–8029. 19 indexed citations
17.
Kacsó, Gabriel, Zsolt Fekete, S S Popescu, et al.. (2008). Long Term Results of Curative Intent Chemoradiation for Muscle Invading Bladder Cancer. International Journal of Radiation Oncology*Biology*Physics. 72(1). S341–S341. 1 indexed citations
18.
Ciuleanu, Tudor–Eliade, et al.. (2007). Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.. PubMed. 12(1). 33–9. 5 indexed citations
19.
Ribrag, Vincent, Serge Koscielny, Ioana Carpiuc, et al.. (2003). Prognostic value of GST-π expression in diffuse large B-cell lymphomas. Leukemia. 17(5). 972–977. 23 indexed citations
20.
Ribrag, Vincent, Frédéric Bibeau, Amr El Weshi, et al.. (2001). Primary breast lymphoma: a report of 20 cases. British Journal of Haematology. 115(2). 253–256. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zebing Liu Breakdown of academic impact, for papers by Sandeep Reddy Breakdown of academic impact, for papers by Shih-Chen Yu Breakdown of academic impact, for papers by Laura López-Vicente Breakdown of academic impact, for papers by Ulla Aspenblad Breakdown of academic impact, for papers by Alexandr O. Ivantsov Breakdown of academic impact, for papers by Véronique Cabaret Breakdown of academic impact, for papers by Annie Jean Breakdown of academic impact, for papers by Karin Tyburski
Rankless by CCL
2026